File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1046/j.1525-1500.1999.99043.x
- Scopus: eid_2-s2.0-0032828543
- PMID: 10468891
- WOS: WOS:000082300700005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Role of serial tumor markers in the surveillance for recurrence in endometrial cancer
Title | Role of serial tumor markers in the surveillance for recurrence in endometrial cancer |
---|---|
Authors | |
Keywords | CA125 CA15.3 CA19.9 Endometrial cancer Recurrence |
Issue Date | 1999 |
Publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/cdp |
Citation | Cancer Detection And Prevention, 1999, v. 23 n. 5, p. 397-400 How to Cite? |
Abstract | The aim of this study is to evaluate the usefulness of tumor markers in the follow-up of patients with endometrial cancer. The sera of 23 patients with elevated pretreatment CA125, CA15.3, and CA19.9 were collected at each follow-up visit and analyzed. Eleven patients had normal posttreatment levels and none of them developed recurrence. Twelve patients had one or more increased tumor markers, 7 (58.3%) of them developed recurrence. Among these seven patients, six had CA 125 elevated by at least 10-fold and one had elevated CA 19.9. The median lead time between elevation of tumor markers and clinical evidence of recurrence was 6 months. Hence posttreatment elevation of CA 125 is a useful predictor for recurrence in patients with elevated pretreatment levels. |
Persistent Identifier | http://hdl.handle.net/10722/87134 |
ISSN | 2011 Impact Factor: 2.522 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lo, SST | en_HK |
dc.contributor.author | Khoo, US | en_HK |
dc.contributor.author | Cheng, DKL | en_HK |
dc.contributor.author | Ng, TY | en_HK |
dc.contributor.author | Wong, LC | en_HK |
dc.contributor.author | Ngan, HYS | en_HK |
dc.date.accessioned | 2010-09-06T09:25:46Z | - |
dc.date.available | 2010-09-06T09:25:46Z | - |
dc.date.issued | 1999 | en_HK |
dc.identifier.citation | Cancer Detection And Prevention, 1999, v. 23 n. 5, p. 397-400 | en_HK |
dc.identifier.issn | 0361-090X | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/87134 | - |
dc.description.abstract | The aim of this study is to evaluate the usefulness of tumor markers in the follow-up of patients with endometrial cancer. The sera of 23 patients with elevated pretreatment CA125, CA15.3, and CA19.9 were collected at each follow-up visit and analyzed. Eleven patients had normal posttreatment levels and none of them developed recurrence. Twelve patients had one or more increased tumor markers, 7 (58.3%) of them developed recurrence. Among these seven patients, six had CA 125 elevated by at least 10-fold and one had elevated CA 19.9. The median lead time between elevation of tumor markers and clinical evidence of recurrence was 6 months. Hence posttreatment elevation of CA 125 is a useful predictor for recurrence in patients with elevated pretreatment levels. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/cdp | en_HK |
dc.relation.ispartof | Cancer Detection and Prevention | en_HK |
dc.rights | Cancer Detection and Prevention. Copyright © Elsevier Inc. | en_HK |
dc.subject | CA125 | en_HK |
dc.subject | CA15.3 | en_HK |
dc.subject | CA19.9 | en_HK |
dc.subject | Endometrial cancer | en_HK |
dc.subject | Recurrence | en_HK |
dc.subject.mesh | CA-125 Antigen - blood | en_HK |
dc.subject.mesh | CA-19-9 Antigen - blood | en_HK |
dc.subject.mesh | Endometrial Neoplasms - diagnosis - surgery - therapy | en_HK |
dc.subject.mesh | Female | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Mucin-1 - blood | en_HK |
dc.subject.mesh | Prognosis | en_HK |
dc.subject.mesh | Recurrence | en_HK |
dc.subject.mesh | Tumor Markers, Biological | en_HK |
dc.title | Role of serial tumor markers in the surveillance for recurrence in endometrial cancer | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0361-090X&volume=23&spage=&epage=&date=1999&atitle=Role+of+serial+tumor+markers+in+the+surveillance+for+recurrence+in+endometrial+cancer | en_HK |
dc.identifier.email | Khoo, US:uskhoo@hkucc.hku.hk | en_HK |
dc.identifier.email | Ngan, HYS:hysngan@hkucc.hku.hk | en_HK |
dc.identifier.authority | Khoo, US=rp00362 | en_HK |
dc.identifier.authority | Ngan, HYS=rp00346 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1046/j.1525-1500.1999.99043.x | en_HK |
dc.identifier.pmid | 10468891 | en_HK |
dc.identifier.scopus | eid_2-s2.0-0032828543 | en_HK |
dc.identifier.hkuros | 42779 | en_HK |
dc.identifier.volume | 23 | en_HK |
dc.identifier.issue | 5 | en_HK |
dc.identifier.spage | 397 | en_HK |
dc.identifier.epage | 400 | en_HK |
dc.identifier.isi | WOS:000082300700005 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Lo, SST=15518872700 | en_HK |
dc.identifier.scopusauthorid | Khoo, US=7004195799 | en_HK |
dc.identifier.scopusauthorid | Cheng, DKL=7402806161 | en_HK |
dc.identifier.scopusauthorid | Ng, TY=7402229853 | en_HK |
dc.identifier.scopusauthorid | Wong, LC=7402092003 | en_HK |
dc.identifier.scopusauthorid | Ngan, HYS=34571944100 | en_HK |
dc.identifier.issnl | 0361-090X | - |